BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7207495)

  • 1. The enhancement of the effect of aflatoxin B1 by metabolic activation with rat-liver microsomes on human lymphocytes assayed with the micronucleus test.
    Iskandar O; Vijayalaxmi
    Mutat Res; 1981 Jan; 91(1):63-6. PubMed ID: 7207495
    [No Abstract]   [Full Text] [Related]  

  • 2. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of aflatoxin B1: observations in vivo and their relation to in vitro activation.
    Fabry L; Roberfroid M
    Toxicol Lett; 1981 Jan; 7(3):245-50. PubMed ID: 6784281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver.
    Buening MK; Fortner JG; Kappas A; Corney AH
    Biochem Biophys Res Commun; 1978 May; 82(1):348-55. PubMed ID: 352361
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenicity of 3a,8a-dihydrofuro[2,3-b]benzofuran, a model of aflatoxin B1, for Salmonella typhimurium TA100.
    Coles BF; Smith JR; Garner RC
    Biochem Biophys Res Commun; 1977 Jun; 76(3):888-92. PubMed ID: 332158
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential.
    Wong JJ; Hsieh DP
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2241-4. PubMed ID: 781672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of aflatoxins related to their mutagenicity.
    Gurtoo HL; Dahms RP; Paigen B
    Biochem Biophys Res Commun; 1978 Apr; 81(3):965-72. PubMed ID: 352354
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of hepatic microsome-mediated bacterial mutagenesis by the rat liver soluble protein fraction.
    Saccone GT; Pariza MW
    Mutat Res; 1981 Feb; 88(2):135-45. PubMed ID: 7012606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system.
    Coulombe RA; Shelton DW; Sinnhuber RO; Nixon JE
    Carcinogenesis; 1982; 3(11):1261-4. PubMed ID: 6758974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lysis in lysogenic bacteria by liver microsomal metabolites of aflatoxin B1.
    Buch JK; Dave PJ
    Indian J Exp Biol; 1980 Oct; 18(10):1162-4. PubMed ID: 6783510
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study on the metabolism and activation of aflatoxin B1 in nuclet, microsomes and reconstituted P-450 system of rat liver.
    Ueno Y; Yoshizawa H; Uchimaru R
    Dev Toxicol Environ Sci; 1980; 8():279-82. PubMed ID: 6796374
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of mutagenicity of diphenylhydantoin in in vitro short-term tests.
    LĂ©onard A; de Meester C; Fabry L; de Saint-Georges L; Dumont P
    Mutat Res; 1984; 137(2-3):79-88. PubMed ID: 6433192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1.
    Robertson LG; Philpot RM; Zeiger E; Wolf CR
    Mol Pharmacol; 1981 Nov; 20(3):662-8. PubMed ID: 6799775
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.